Aortoiliac arterial thrombosis and renal artery stenosis in a patient with neonatal multisystem inflammatory syndrome: a case report and review of literature.
{"title":"Aortoiliac arterial thrombosis and renal artery stenosis in a patient with neonatal multisystem inflammatory syndrome: a case report and review of literature.","authors":"Oranooj Lertkovit, Daranee Isaranimitkul, Suwanna Pornrattanarungsri, Ornatcha Sirimongkolchaiyakul, Sirikarn Tangcheewinsirikul, Pichada Saengrat","doi":"10.3389/fped.2024.1474192","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multisystem inflammatory syndrome in neonates (MIS-N) is a rare condition thought to be associated with prenatal exposure to maternal severe acute respiratory syndrome coronavirus 2 infection. This immune-mediated hyperinflammation has been described in neonates with multiorgan dysfunction, including cardiopulmonary, encephalopathy, coagulopathy, and vascular complications. However, renovascular complications in MIS-N are rare. Here, we present a case with aortoiliac arterial thrombosis and renovascular stenosis in MIS-N.</p><p><strong>Case presentation: </strong>A 2-day-old, full-term, male neonate presented with fever, respiratory failure, hypotensive shock, and elevated inflammatory markers. He was transferred to our neonatal intensive care unit for comprehensive monitoring and treated with antibiotics for early-onset neonatal sepsis. However, his clinical condition deteriorated. His mother reported a history of severe acute respiratory syndrome coronavirus 2 infection during the late second trimester. He was diagnosed with MIS-N based on the fulfillment of the diagnostic criteria for multiorgan involvement and laboratory findings. He responded to intravenous immunoglobulin, corticosteroids, and aspirin. However, he later developed significant hypertension, which was associated with aortoiliac arterial thrombosis and right renal artery stenosis. An elevated ferritin level was observed. The ongoing inflammatory condition was considered, and corticosteroids were restarted along with treatment for documented thrombosis using enoxaparin and aspirin. After treatment, partial resolution of aortoiliac arterial thrombus was observed. However, narrowing of the proximal part of right renal artery persisted, and blood pressure remained difficult to control, requiring multiple antihypertensive agents. Finally, the patient underwent percutaneous transluminal balloon angioplasty to control hypertension.</p><p><strong>Conclusion: </strong>Our case revealed the clinical course of MIS-N with renovascular complications. The condition's hyperinflammatory state may have played a pathophysiological role in the development of this life-threatening complication. Although there is an increased risk of bleeding in MIS-N, thromboprophylaxis should be considered in high-risk patients. An early multidisciplinary approach is recommended to ensure prompt diagnosis and improve outcomes.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"12 ","pages":"1474192"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757169/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fped.2024.1474192","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Multisystem inflammatory syndrome in neonates (MIS-N) is a rare condition thought to be associated with prenatal exposure to maternal severe acute respiratory syndrome coronavirus 2 infection. This immune-mediated hyperinflammation has been described in neonates with multiorgan dysfunction, including cardiopulmonary, encephalopathy, coagulopathy, and vascular complications. However, renovascular complications in MIS-N are rare. Here, we present a case with aortoiliac arterial thrombosis and renovascular stenosis in MIS-N.
Case presentation: A 2-day-old, full-term, male neonate presented with fever, respiratory failure, hypotensive shock, and elevated inflammatory markers. He was transferred to our neonatal intensive care unit for comprehensive monitoring and treated with antibiotics for early-onset neonatal sepsis. However, his clinical condition deteriorated. His mother reported a history of severe acute respiratory syndrome coronavirus 2 infection during the late second trimester. He was diagnosed with MIS-N based on the fulfillment of the diagnostic criteria for multiorgan involvement and laboratory findings. He responded to intravenous immunoglobulin, corticosteroids, and aspirin. However, he later developed significant hypertension, which was associated with aortoiliac arterial thrombosis and right renal artery stenosis. An elevated ferritin level was observed. The ongoing inflammatory condition was considered, and corticosteroids were restarted along with treatment for documented thrombosis using enoxaparin and aspirin. After treatment, partial resolution of aortoiliac arterial thrombus was observed. However, narrowing of the proximal part of right renal artery persisted, and blood pressure remained difficult to control, requiring multiple antihypertensive agents. Finally, the patient underwent percutaneous transluminal balloon angioplasty to control hypertension.
Conclusion: Our case revealed the clinical course of MIS-N with renovascular complications. The condition's hyperinflammatory state may have played a pathophysiological role in the development of this life-threatening complication. Although there is an increased risk of bleeding in MIS-N, thromboprophylaxis should be considered in high-risk patients. An early multidisciplinary approach is recommended to ensure prompt diagnosis and improve outcomes.
期刊介绍:
Frontiers in Pediatrics (Impact Factor 2.33) publishes rigorously peer-reviewed research broadly across the field, from basic to clinical research that meets ongoing challenges in pediatric patient care and child health. Field Chief Editors Arjan Te Pas at Leiden University and Michael L. Moritz at the Children''s Hospital of Pittsburgh are supported by an outstanding Editorial Board of international experts. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Frontiers in Pediatrics also features Research Topics, Frontiers special theme-focused issues managed by Guest Associate Editors, addressing important areas in pediatrics. In this fashion, Frontiers serves as an outlet to publish the broadest aspects of pediatrics in both basic and clinical research, including high-quality reviews, case reports, editorials and commentaries related to all aspects of pediatrics.